New Delhi:
The government today approved the inclusion of an intranasal Covid vaccine in the vaccination programme as a booster dose for adults. The inclusion comes amid a surge in cases in China and some other countries.
Here’s your 5-point cheatsheet on the nasal vaccine:
-
The two-drop India-made nasal vaccine, iNCOVACC, will be introduced on the Co-WIN platform this evening.
-
The vaccine, manufactured by Bharat Biotech, will only be available at private centres for now.
-
Those who have taken Covishield and Covaxin can take the nasal vaccine as a heterologous booster dose.
-
In heterologous boosting, a person administered a different vaccine from the one that was used for the primary dose series.
-
The needle-free vaccine received approval of the Drugs Controller General of India in November for restricted use in an emergency situation.
Featured Video Of The Day
New Covid Alert: Too Soon For Curbs Or Should We Worry?
